Literature DB >> 10787364

Hyponatremia, cerebral edema, and noncardiogenic pulmonary edema in marathon runners.

J C Ayus1, J Varon, A I Arieff.   

Abstract

BACKGROUND: Noncardiogenic pulmonary edema is often associated with increased intracranial pressure and can be the initial manifestation of hyponatremic encephalopathy. Marathon runners tend to develop conditions that lead to hyponatremia.
OBJECTIVE: To describe the development and treatment of noncardiogenic pulmonary edema in marathon runners that was associated with hyponatremic encephalopathy.
DESIGN: Case series.
SETTING: One university hospital and two community hospitals. PATIENTS: Seven healthy marathon runners who had a history of nonsteroidal anti-inflammatory drug use. The runners collapsed after competing in a marathon and were hospitalized with pulmonary edema. MEASUREMENTS: Plasma sodium levels, chest radiograph, electrocardiogram, cardiac enzyme levels, and magnetic resonance imaging or computed tomographic scans of the brain.
RESULTS: Patients had nausea, emesis, and obtundation. The mean (+/-SD) plasma sodium level was 121 +/- 3 mmol/L, and oxygen saturation was less than 70%. Electrocardiograms and echocardiograms were normal. Chest radiographs showed pulmonary edema with a normal heart. Creatine phosphokinase-MB bands, troponin levels, and pulmonary wedge pressure were not elevated. Scanning of the brain showed cerebral edema. All patients were intubated and mechanically ventilated. Treatment with intravenous NaCl, 514 mmol/L, increased plasma sodium levels by 10 mmol/L in 12 hours. Pulmonary and cerebral edema resolved as the sodium level increased. One patient had unsuspected hyponatremic encephalopathy and died of cardiopulmonary arrest caused by brainstem herniation. All six treated patients recovered and were well after 1 year of follow-up.
CONCLUSIONS: In healthy marathon runners, noncardiogenic pulmonary edema can be associated with hyponatremic encephalopathy. The condition may be fatal if undiagnosed and can be successfully treated with hypertonic NaCl.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10787364     DOI: 10.7326/0003-4819-132-9-200005020-00005

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  69 in total

1.  Ecstacy-associated hyponatremia: why are women at risk?

Authors:  Michael L Moritz; Kamyar Kalantar-Zadeh; Juan Carlos Ayus
Journal:  Nephrol Dial Transplant       Date:  2013-06-26       Impact factor: 5.992

2.  Three independent biological mechanisms cause exercise-associated hyponatremia: evidence from 2,135 weighed competitive athletic performances.

Authors:  T D Noakes; K Sharwood; D Speedy; T Hew; S Reid; J Dugas; C Almond; P Wharam; L Weschler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

3.  Case proven: exercise associated hyponatraemia is due to overdrinking. So why did it take 20 years before the original evidence was accepted?

Authors:  T D Noakes; D B Speedy
Journal:  Br J Sports Med       Date:  2006-07       Impact factor: 13.800

4.  Hyponatraemia : identification and evaluation in the marathon medical area.

Authors:  Joseph N Chorley
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

5.  [Hyponatremia].

Authors:  Alexandra Scholze; Martin Tepel
Journal:  Med Klin (Munich)       Date:  2009-02-15

Review 6.  Managing collapsed or seriously ill participants of ultra-endurance events in remote environments.

Authors:  Martin D Hoffman; Ian R Rogers; Jeremy Joslin; Chad A Asplund; William O Roberts; Benjamin D Levine
Journal:  Sports Med       Date:  2015-02       Impact factor: 11.136

7.  Fluid intake and changes in limb volumes in male ultra-marathoners: does fluid overload lead to peripheral oedema?

Authors:  Alexia Bracher; Beat Knechtle; Markus Gnädinger; Jolanda Bürge; Christoph Alexander Rüst; Patrizia Knechtle; Thomas Rosemann
Journal:  Eur J Appl Physiol       Date:  2011-07-01       Impact factor: 3.078

Review 8.  Hyponatremia and bone disease.

Authors:  Armando Luis Negri; Juan Carlos Ayus
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

9.  Management of hyponatremia in various clinical situations.

Authors:  Michael L Moritz; Juan C Ayus
Journal:  Curr Treat Options Neurol       Date:  2014-09       Impact factor: 3.598

Review 10.  New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children.

Authors:  Michael L Moritz; Juan Carlos Ayus
Journal:  Pediatr Nephrol       Date:  2009-11-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.